Chest Mobility, Strength, Physical Activity and Quality of Life in Parkinson's Patients With Post-COVID-19

CompletedOBSERVATIONAL
Enrollment

32

Participants

Timeline

Start Date

May 13, 2023

Primary Completion Date

August 30, 2024

Study Completion Date

December 30, 2024

Conditions
COVID-19 Respiratory InfectionParkinson Disease
Interventions
OTHER

Physical Evaluations of post-COVID-19 individuals

In this research, the data of Parkinson's patients who have had COVID-19 will be collected face to face. Chest mobility, cough strength, muscle strength, physical activity and quality of life will be evaluated in all Parkinson's patients. The data to be obtained through all these evaluations will be collected from at one time and in a time lasting maximum of about 1 hour. Step count tracking with pedometer will be done for 3 days for each individual.

OTHER

Physical Evaluations of non-post-COVID-19 individuals

In this research, the data of Parkinson's patients who have not had COVID-19 will be collected face to face. Chest mobility, cough strength, muscle strength, physical activity and quality of life will be evaluated in all Parkinson's patients. The data to be obtained through all these evaluations will be collected from at one time and in a time lasting maximum of about 1 hour. Step count tracking with pedometer will be done for 3 days for each individual.

Trial Locations (1)

35140

Izmir Democracy University, Izmir

All Listed Sponsors
lead

Izmir Democracy University

OTHER

NCT06008444 - Chest Mobility, Strength, Physical Activity and Quality of Life in Parkinson's Patients With Post-COVID-19 | Biotech Hunter | Biotech Hunter